A subscription to JoVE is required to view this content. Sign in or start your free trial.
The blood-brain barrier is a significant hurdle in the delivery of therapies for glioblastoma, a disease for which there is no cure. Here, we report an in vivo image-guided iron oxide therapeutic nano platform that can bypass this physiological barrier by virtue of size and accumulate in the tumor.
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain malignancy for which there is no cure. The blood-brain barrier is a significant hurdle in the delivery of therapies to GBM. Reported here is an image-guided, iron oxide-based therapeutic delivery nano platform capable of bypassing this physiological barrier by virtue of size and accumulating in the tumor region, delivering its payload. This 25 nm nano platform consists of crosslinked dextran-coated iron oxide nanoparticles labeled with Cy5.5 fluorescent dye and containing antisense oligonucleotide as a payload. The magnetic iron oxide core enables tracking of the nanoparticles through in vivo magnetic resonance imaging, while Cy5.5 dye allows tracking by optical imaging. This report details the monitoring of the accumulation of this nanoparticle platform (termed MN-anti-miR10b) in orthotopically implanted glioblastoma tumors following intravenous injection. In addition, it provides insight into the in vivo delivery of RNA oligonucleotides, a problem that has hampered the translation of RNA therapeutics into the clinic.
Glioblastoma multiforme (GBM) is the highest grade of astrocytoma for which there is virtually no cure. Approximately 15,000 people are diagnosed with glioblastoma annually, which has a dismal median survival of about 15 months and a 5-year survival rate of 5%1. In the past decades, there has been marginal improvement in prognosis despite multiple efforts to advance therapeutic options. The current standard of care for GBM includes maximal surgical resection, when feasible, followed by radiotherapy and chemotherapy2. Temozolomide (TMZ), the chemotherapy of choice, was the latest therapy for glioblastoma discovered to sho....
All procedures involving animal subjects have been approved by the Michigan State University Institutional Animal Care and Use Committee (IACUC). Female outbred athymic nude mice were purchased from Jackson Labs (strain #007850) at 7 weeks of age and allowed to acclimate for 1 week prior to implantation surgery. Mice were approximately 21-25 g at the time of implant. U251 cells expressing firefly luciferase were generated and provided by Dr. Ana deCarvalho12.
1. C.......
MN-anti-miR10b was synthesized and characterized, as described previously11. Transmission electron microscopy of MN-anti-miR10b shows the morphology and polydispersity of the nano platform (Figure 1B). This nano platform has an average size of 25.12 ± 0.34 nm with a zeta potential of 13.18 ± 1.47 mV (Figure 1C,D). In these studies, nude athymic mice were orthotopically implanted with U251 human .......
Several critical steps across the different methods of validating the accumulation of the nanoparticles across the BBB can be decisive for the success of the protocol. Beginning with the orthotopic implantation of GBM cells, it is important to ensure that the suture lines of the skull are visible after drying the bone; this aids in the accurate placement of the tumor cells. For drilling through the skull, it is best to apply light pressure to the drill site and begin drilling to make a shallow impression in the bone. Onc.......
The Funding for this study was provided in part by the grant from the Henry Ford Health Systems Michigan State University Health Sciences Alliance to A.M. and A.dC. We thank Dr. Danielle R. Ferguson for overseeing animal studies at Michigan State University and for approving this video.
....Name | Company | Catalog Number | Comments |
Athymic nude "J:NU" mice | Jackson Laboratory | RRID:IMSR_JAX:007850 | Immunocompromised mouse model |
0.25% Trypsin | Gibco | 25200-056 | Cell culture reagent for U251 |
1.7 mL microcentrifuge tube | DOT Scientific | RN1700-GMT | For tissue collection |
10 µL, Neuros Syringe, Model 1701 RN, 33 gauge, Point Style 4 | Hamilton | 65460-06 | Syringe for intracranial implantation of tumor cells |
3M Vetbond | 3M | 1469SB | Tissue adhesive for surgical site closure |
4% Paraformaldehyde | Thermo Scientific | J199943-K2 | Tissue fixing solution |
70% isopropoyl alcohol wipe | Cardinal | MW-APL | Topical antiseptic wipe for tumor implantation and tail vein injection |
Aperio Versa | Leica | For scanning of stained tissue section slides | |
Betadine Surgical Scrub | Purdue | 6761815101 | Topical antiseptic for tumor implantation |
BioSpec 70/30 | Bruker | Magnetic resonance imaging scanner | |
Bone Wax | Medline | DYNJBW25 | Bone wax for sealing implantation site |
Burrs for Micro drill | F.S.T. | 19007-05 | Drill burr used to make hole in skull for tumor implantation |
DAPI Fluoromount-G | SouthernBiotech | 0100-20 | Tissue mounting media containing DAPI stain |
Dulbecco’s Modified Eagle Medium (DMEM) | Gibco | 11995-065 | Cell culture media for U251 |
Extra Fine Graefe Forceps | F.S.T. | 11150-10 | Sugical tool for tumor implantation |
Fetal bovine serum | Corning | 35-010-CV | Cell culture media supplement for U251 |
Fine Scissors - Sharp 10.5cm | F.S.T. | 14060-10 | Sugical tool for tumor implantation |
Glydo (Lidocaine) | Sagent | 673-76 | Topical analgesic for surgical site |
Ideal Micro Drill | CellPoint Scientific | 67-1200A | Drill used to make hole in skull for tumor implantation |
Insulin syringe 1CC 29G X 1/2" | Becton, Dickinson | 324704 | Syringe for D-Luciferin injection and tail vein injection of nanoparticles |
Isoflurane | Covetrus | 11695067772 | Anethesia |
Isoflurane vaporizer | SOMNI Scientific | VS6002 | Anethesia apparatus |
IVIS SpectrumCT In Vivo Imaging System | PerkinElmer/Revvity | 128201 | Bioluminescence and fluorescence imaging scanner |
IVISbrite D-Luciferin Potassium Salt | PerkinElmer/Revvity | 122799-100MG | Substrate for bioluminescence imaging |
Ketaset (Ketamine) | Zoetis | 10004027 | Anesthetic for tumor implantation surgery |
Ketofen (Ketoprofen) | Zoetis | 10004031 | Analgesic for tumor implantation surgery |
Leica CM1950 | Leica | CM1950 | For cryosectioning of OCT-embedded samples |
PBS | Gibco | 14190-144 | Cell culture reagent and cell suspension solution for implantation of U251 |
Penicillin-streptomycin | Gibco | 15140-122 | Antibiotic for cell culture media for U251 |
Puralube vet ointment | MWI Veterinary | 27505 | Opthalmic eye ointment for protection during tumor implantation |
Ruler | F.S.T. | 18000-30 | Used to measure drill site for implanation |
Tissue-Tek Cryomold Intermediate 15 x 15 x 5 mm | Sakura | 4566 | Collection mold for collecting tissue samples |
Tissue-Tek O.C.T. Compound | Sakura | 4583 | Freezing compound for collecting tissue samples |
U-251 MG cell line human | Millapore Sigma | 9063001 | Human glioblastoma cell line |
Xylazine Injectable Solution, 100 mg/ml | Covetrus | 1XYL006 | Paralytic for tumor implantation surgery |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved